Market Cap | 53.65M | P/E | - | EPS this Y | 33.90% | Ern Qtrly Grth | - |
Income | -38.99M | Forward P/E | -3.63 | EPS next Y | 51.90% | 50D Avg Chg | -5.00% |
Sales | - | PEG | -1.72 | EPS past 5Y | - | 200D Avg Chg | 66.00% |
Dividend | N/A | Price/Book | 14.83 | EPS next 5Y | 15.00% | 52W High Chg | -23.00% |
Recommedations | 1.50 | Quick Ratio | 14.75 | Shares Outstanding | 33.41M | 52W Low Chg | 464.00% |
Insider Own | 2.01% | ROA | -23.33% | Shares Float | 13.71M | Beta | -1.54 |
Inst Own | 94.91% | ROE | -46.45% | Shares Shorted/Prior | 3.10M/2.30M | Price | 4.79 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 103,212 | Target Price | 64.33 |
Oper. Margin | - | Earnings Date | May 7 | Volume | 16,248 | Change | -3.23% |
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
Piper Sandler | Overweight | Feb 5, 24 |
Stifel | Buy | Jan 23, 24 |
Oppenheimer | Outperform | Jan 2, 24 |
Cantor Fitzgerald | Overweight | Sep 26, 23 |
Oppenheimer | Outperform | Sep 15, 23 |
Cantor Fitzgerald | Overweight | Aug 31, 23 |
Cantor Fitzgerald | Overweight | Jul 11, 23 |
Oppenheimer | Outperform | May 25, 23 |
Oppenheimer | Outperform | Mar 24, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Yen Kristen | SEE REMARKS SEE REMARKS | Jan 25 | Sell | 48.30 | 397 | 19,175 | 25,640 | 01/29/24 |
Hirano Patricia C | SEE REMARKS SEE REMARKS | Jan 25 | Sell | 48.30 | 832 | 40,186 | 43,142 | 01/29/24 |
Anish Bhatnagar | CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER | Jan 25 | Sell | 48.30 | 2,527 | 122,054 | 171,770 | 01/29/24 |
Hirano Patricia C | See Remarks See Remarks | Dec 13 | Sell | 37.64 | 6,244 | 235,024 | 19,974 | 12/15/23 |
Yen Kristen | See Remarks See Remarks | Dec 12 | Sell | 37.14 | 37,829 | 1,404,969 | 2,037 | 12/14/23 |
Yen Kristen | See Remarks See Remarks | Dec 12 | Option | 2.5 | 17,916 | 44,790 | 19,953 | 12/14/23 |
Anish Bhatnagar | Chief Executive Offi.. Chief Executive Officer | Dec 11 | Sell | 36.09 | 93,408 | 3,371,095 | 24,297 | 12/13/23 |
Mackaness James H | Chief Financial Offi.. Chief Financial Officer | Dec 11 | Sell | 36.24 | 32,482 | 1,177,148 | 12,128 | 12/13/23 |
Mackaness James H | Chief Financial Offi.. Chief Financial Officer | Dec 11 | Option | 2.6 | 15,000 | 39,000 | 44,610 | 12/13/23 |
Anish Bhatnagar | Chief Executive Offi.. Chief Executive Officer | Oct 20 | Option | 2.92 | 9,643 | 28,158 | 198,926 | 12/13/23 |
Mackaness James H | Chief Financial Offi.. Chief Financial Officer | Oct 02 | Option | 2.92 | 8,309 | 24,262 | 41,879 | 12/13/23 |
Yen Kristen | See Remarks See Remarks | Nov 30 | Sell | 28.6519 | 3,963 | 113,547 | 21,950 | 12/04/23 |
Mackaness James H | Chief Financial Offi.. Chief Financial Officer | Nov 30 | Sell | 28.6519 | 4,186 | 119,937 | 21,303 | 12/04/23 |
Hirano Patricia C | See Remarks See Remarks | Nov 30 | Sell | 28.6519 | 3,823 | 109,536 | 26,218 | 12/04/23 |
Anish Bhatnagar | Chief Executive Offi.. Chief Executive Officer | Nov 30 | Sell | 28.6519 | 27,716 | 794,116 | 108,062 | 12/04/23 |
Yen Kristen | See Remarks See Remarks | Nov 28 | Sell | 27.58 | 7,650 | 210,987 | 25,913 | 11/30/23 |
Mackaness James H | Chief Financial Offi.. Chief Financial Officer | Nov 28 | Sell | 27.58 | 8,081 | 222,874 | 25,489 | 11/30/23 |
Hirano Patricia C | See Remarks See Remarks | Nov 28 | Sell | 27.58 | 7,381 | 203,568 | 30,041 | 11/30/23 |
Anish Bhatnagar | Chief Executive Offi.. Chief Executive Officer | Nov 28 | Sell | 27.58 | 53,505 | 1,475,668 | 135,778 | 11/30/23 |
PERCEPTIVE ADVISORS LLC | 10% Owner 10% Owner | Sep 26 | Buy | 14.76 | 866,789 | 12,793,806 | 3,074,542 | 09/28/23 |
PERCEPTIVE ADVISORS LLC | 10% Owner 10% Owner | May 24 | Buy | 5.31 | 85,000 | 451,350 | 2,029,455 | 05/26/23 |
PERCEPTIVE ADVISORS LLC | 10% Owner 10% Owner | May 19 | Buy | 5.06 | 80,000 | 404,800 | 1,944,455 | 05/23/23 |
SCHULER JACK W | 10% Owner 10% Owner | Aug 02 | Sell | 2.64 | 180,523 | 476,581 | 466,666 | 10/14/22 |
Anish Bhatnagar | Chief Executive Offi.. Chief Executive Officer | Jan 21 | Sell | 0.373 | 39,033 | 14,559 | 370,227 | 01/25/22 |